In silico ADME/T modelling for rational drug design. Issue 4 (2nd September 2015)

• Record Type: Journal Article
• Authors: Wang, Yulan; Xing, Jing; Xu, Yuan; Zhou, Nannan; Peng, Jianlong; Xiong, Zhaoping; Liu, Xian; Luo, Xiaomin; Luo, Cheng; Chen, Kaixian; Zheng, Mingyue; Jiang, Hualiang
• Is Part Of: Quarterly reviews of biophysics. Volume 48:Issue 4(2015)
• Page Start: 488
• Page End: 515
• Publication Date: 2015-09-02
• Subjects: ADME/T, -- Drug Design, -- Pharmacokinetics, -- Predictive Toxicology, -- QSAR; Biophysics -- Periodicals; 571.405
• DOI: 10.1017/S0033583515000190
• Languages: English
• ISSNs: 0033-5835

Abstract

Abstract: In recent decades, in silico absorption, distribution, metabolism, excretion (ADME), and toxicity (T) modelling as a tool for rational drug design has received considerable attention from pharmaceutical scientists, and various ADME/T-related prediction models have been reported. The high-throughput and low-cost nature of these models permits a more streamlined drug development process in which the identification of hits or their structural optimization can be guided based on a parallel investigation of bioavailability and safety, along with activity. However, the effectiveness of these tools is highly dependent on their capacity to cope with needs at different stages, e.g. their use in candidate selection has been limited due to their lack of the required predictability. For some events or endpoints involving more complex mechanisms, the current in silico approaches still need further improvement. In this review, we will briefly introduce the development of in silico models for some physicochemical parameters, ADME properties and toxicity evaluation, with an emphasis on the modelling approaches thereof, their application in drug discovery, and the potential merits or deficiencies of these models. Finally, the outlook for future ADME/T modelling based on big data analysis and systems sciences will be discussed.